Further studies are therefore necessary to evaluate the differences in prognosis among VA-ECMO patients, or more generally after cardiac arrest, between 21 and 4 electrodes in a multimodal approach (combining clinical examination, blood neuron-specific enolase, and imaging). This evidence concerns the gene ENO2 and cardiac arrest.